MiR-374-5p has been shown to repress development of breast cancer through TATA-box binding protein associated factor 7 (TAF7)-mediated transcriptional regulation of DEP domain containing 1 (DEPDC1) [39]. Here, DEPDC1 is linked to breast carcinoma.